Ion Beam Applications SA 2014 AR2
The report highlights IBA's performance in 2014, showcasing a 3.8% increase in total revenues to EUR 220.6 million and a record year-end backlog of EUR 256.2 million. The company secured six new contracts for its proton therapy systems, representing over 50% of the global market share in 2014. Key milestones included receiving FDA and CE mark approvals for the Compact Gantry Beam Line and the Cone Beam CT solution for the Proteus_x0000_ONE system. On the sustainability front, the employee-led "Green Cell" initiative focused on reducing the company's environmental footprint through waste management, mobility, and energy projects, including installing photovoltaic panels on the assembly hall roof.
Company: Ion Beam Applications SA
Sector: Manufacturing
Country: Belgium
Year: 2014
Type: AR2
Pages: 152
Back to company
Ion Beam Applications SA
Annual Report
The report highlights IBA's performance in 2014, showcasing a 3.8% increase in total revenues to EUR 220.6 million and a record year-end backlog of EUR 256.2 million. The company secured six new contracts for its proton therapy systems, representing over 50% of the global market share in 2014. Key milestones included receiving FDA and CE mark approvals for the Compact Gantry Beam Line and the Cone Beam CT solution for the Proteus_x0000_ONE system. On the sustainability front, the employee-led "Green Cell" initiative focused on reducing the company's environmental footprint through waste management, mobility, and energy projects, including installing photovoltaic panels on the assembly hall roof.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2014
Reporting Period
Jan 1, 2014 - Dec 31, 2014
Fiscal Year
2014
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees